Viewing nowCoshiba Tablets 20 mg (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Dasan Pharmaceuticals Co., Ltd.

MFDS item code 201801491 · Approved 2018.04.04
Improvement of hyperlipidemia, improvement of pediatric familial hypercholesterolemia, and prevention of cardiovascular disease
This medication helps reduce the risk of mortality from coronary heart disease, non-fatal myocardial infarction, and stroke, as well as the risk of revascularization procedures in adult patients at high risk for cardiovascular diseases. Additionally, it is effective in lowering total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels while increasing HDL cholesterol levels in patients with primary hyperlipidemia and various dyslipidemias, improving overall serum lipid levels. It is also useful for controlling cholesterol levels in patients with homozygous and heterozygous familial hypercholesterolemia when used in conjunction with diet. It is indicated when treatment is needed for pediatric patients with heterozygous familial hypercholesterolemia. Overall, this medication plays an important role in the prevention of cardiovascular diseases and the improvement of dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose appropriately according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is limited to patients who have been taking 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2) See the information below for recommended doses in patients receiving this medicine with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see Precautions for Use, 6. Interactions). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In older adults, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Coadministration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see Precautions for Use, 2. Patients in whom administration is contraindicated) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start treatment at 5 mg once daily and monitor closely.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. The dose should be adjusted appropriately for each patient according to the recommended treatment goal. Dose adjustments should be made at intervals of 4 weeks or more.
This medication is primarily used to treat hypercholesterolemia by inhibiting cholesterol production in the body, thereby lowering blood LDL cholesterol levels. When taking this medication, special attention should be paid to muscle-related side effects. At high doses, muscle pain, muscle weakness, and in severe cases, rhabdomyolysis, which is damage to muscle tissue, may occur; therefore, if symptoms of muscle pain or weakness appear, consultation with a doctor should be sought immediately. It may also affect liver function, so it should not be taken by individuals with liver disease or those with abnormally high liver enzyme levels, and regular liver function tests during treatment are important. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. If planning for pregnancy, consultation with a doctor is essential, and appropriate contraception should be practiced. Furthermore, this medication can interact with various drugs; if taking other medications, it is necessary to inform a doctor or pharmacist. In particular, co-administration with specific antifungal agents, antibiotics, immunosuppressants, and calcium channel blockers may increase the risk of myopathy. Elderly patients, those with impaired kidney function, and patients with hypothyroidism should exercise additional caution when taking this medication, and any unusual symptoms related to the muscles or liver should be reported to medical personnel immediately. During treatment, it is advisable to avoid foods or drinks that affect CYP3A4 metabolism, such as grapefruit juice. In case of overdose, there are no specific antidotes available; therefore, the individual should go to the hospital immediately for appropriate treatment, and medications should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it should be kept at room temperature between 1°C and 30°C, avoiding excessively hot or cold locations.
Brownish-yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Dasan Pharmaceuticals Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.